boswellic acid has been researched along with 8-epi-prostaglandin f2alpha in 1 studies
| Studies (boswellic acid) | Trials (boswellic acid) | Recent Studies (post-2010) (boswellic acid) | Studies (8-epi-prostaglandin f2alpha) | Trials (8-epi-prostaglandin f2alpha) | Recent Studies (post-2010) (8-epi-prostaglandin f2alpha) |
|---|---|---|---|---|---|
| 227 | 15 | 147 | 1,863 | 248 | 723 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghamiri, SH; Aghamollaii, V; Alborzi, AT; Baram, SM; Fotouhi, A; Gharahje, S; Hosseinizadeh, M; Kabiri, S; Karima, S; Lima, BS; Mahdavi, M; Mansouri, B; Rajaei, S; Shahamati, SZ; Shateri, S; Tafakhori, A; Tehrani, HS | 1 |
1 trial(s) available for boswellic acid and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
Functional improvement and immune-inflammatory cytokines profile of ischaemic stroke patients after treatment with boswellic acids: a randomized, double-blind, placebo-controlled, pilot trial.
Topics: Adult; Aged; Aged, 80 and over; Brain Ischemia; Chemokines; Cytokines; Dinoprost; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Stroke; Triterpenes | 2019 |